Search by Drug Name or NDC
NDC 61919-0813-30 ENALAPRIL MALEATE 2.5 mg/1 Details
ENALAPRIL MALEATE 2.5 mg/1
ENALAPRIL MALEATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECT RX. The primary component is ENALAPRIL MALEATE.
MedlinePlus Drug Summary
Enalapril is used alone or in combination with other medications to treat high blood pressure. It is also used in combination with other medications to treat heart failure. Enalapril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 61919-0813-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Enalapril
Product Information
| NDC | 61919-0813 |
|---|---|
| Product ID | 61919-813_fc5dd378-9514-949b-e053-6394a90a3ca2 |
| Associated GPIs | 36100020100303 |
| GCN Sequence Number | 000385 |
| GCN Sequence Number Description | enalapril maleate TABLET 2.5 MG ORAL |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 00963 |
| HICL Sequence Number | 000130 |
| HICL Sequence Number Description | ENALAPRIL MALEATE |
| Brand/Generic | Generic |
| Proprietary Name | ENALAPRIL MALEATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ENALAPRIL MALEATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ENALAPRIL MALEATE |
| Labeler Name | DIRECT RX |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA018998 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0813-30 (61919081330)
| NDC Package Code | 61919-813-30 |
|---|---|
| Billing NDC | 61919081330 |
| Package | 30 TABLET in 1 BOTTLE (61919-813-30) |
| Marketing Start Date | 2019-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |